La. Robinson et al., PULMONARY RESECTION FOR INVASIVE ASPERGILLUS INFECTIONS IN IMMUNOCOMPROMISED PATIENTS, Journal of thoracic and cardiovascular surgery, 109(6), 1995, pp. 1182-1197
Standard antifungal medical therapy of invasive pulmonary aspergillosi
s that occurs in immunocompromised patients with hematologic diseases
with neutropenia or in liver transplant recipients results in less tha
n a 5% survival. In view of these dismal mortality rates, we adopted a
n aggressive approach with resection of the involved area of lung alon
g with systemic antifungal therapy when localized invasive pulmonary a
spergillosis developed in these patients, Between January 1987 and Dec
ember 1993, 14 patients with hematologic diseases and 2 liver transpla
nt recipients underwent resection of acute localized pulmonary masses
suggestive of invasive pulmonary aspergillosis a median of 7.5 days (r
ange 1 to 45 days) after the diagnosis was clinically suggested and co
nfirmed by chest computed tomographic scans, Operative procedures done
included two pneumonectomies, one bilobectomy with limited thoracopla
sty, nine lobectomies, and five wedge resections (one patient with hem
atologic disease had two procedures), All patients were treated before
and after the operation with antifungal agents, Nine (64%) of 14 pati
ents with hematologic disease and 2 (100%) of 2 liver transplant recip
ients survived the hospitalization with no evidence of recurrent Asper
gillus infection after a median 8 months of follow-up (range 3 to 82 m
onths), The five hospital deaths (all patients with hematologic diseas
es) occurred a median of 20 days after operation from diffuse alveolar
hemorrhage in three, graft-versus-host disease in one, and multiple o
rgan system failure with presumed disseminated Aspergillus infection i
n one, Four of the five deaths were in patients with allogeneic bone m
arrow transplants. Two of the three patients requiring resection of mu
ltiple foci of infection died, as did the only patient who was preoper
atively ventilator dependent, In immunocompromised patients with hemat
ologic diseases or liver transplantation with invasive pulmonary asper
gillosis, early pulmonary resection should be strongly considered when
the characteristic clinical and radiographic pictures appear.